Nanalysis Scientific Corp. - NSCIF STOCK NEWS

Welcome to our dedicated news page for Nanalysis Scientific (Ticker: NSCIF), a resource for investors and traders seeking the latest updates and insights on Nanalysis Scientific.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nanalysis Scientific's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nanalysis Scientific's position in the market.

04/11/2024 08:30 AM

News

Nanalysis Announces Full Year 2023 Conference Call

Rhea-AI Summary

Nanalysis Scientific Corp. will host a conference call on April 25th to discuss the results for the quarter and year ending December 31, 2023. The Company is a leader in portable NMR machines and MRI technology for industrial and research applications. Investors can participate in the call online or by phone. An additional Q&A session for European investors will be held on April 26th.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-4.06%

Tags

04/11/2024 08:30 AM

News

/C O R R E C T I O N -- Nanalysis Scientific Corp./

Rhea-AI Summary

Nanalysis Scientific Corp. announces Full Year 2023 Conference Call for April 29th and European Q&A Session for April 30th. The Company will discuss results for the quarter and year ending December 31, 2023, with CEO and CFO hosting the call. Investors can participate via phone or online webcast. European investors can join the Q&A session as well.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

04/10/2024 09:55 AM

News

Nanalysis Scientific Corp. Announces Director Resignation

Rhea-AI Summary

Nanalysis Scientific Corp. announces the resignation of Kham Lin as a director, effective April 9, 2024, with the Board of Directors accepting his resignation. The Company expresses gratitude for Mr. Lin's contributions.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-0.14%

Tags

04/04/2024 08:30 AM

News

Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances

Rhea-AI Summary

Nanalysis Scientific Corp. receives $1.45 million in funding from NRC IRAP to develop AI-based software tools for detecting illicit substances. The project aims to use quantum mechanical modeling and AI to analyze NMR results, identifying both known and unknown designer drugs. The company's non-destructive NMR technology uniquely positions it to assist in this global fight against substance abuse.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-2%

Tags

02/07/2024 08:30 AM

News

Nanalysis Announces Upcoming Webinar and Conference Participation

Rhea-AI Summary

Nanalysis Scientific Corp. announces CEO participation in upcoming webinars and conferences. CEO Sane Krakiwsky to provide business review and update on growth opportunities for the CATSA contract, NMR, and MRI businesses. Investors can register for live events and request one-on-one meetings with management.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

5.93%

Tags

02/06/2024 08:30 AM

News

Nanalysis Achieves Record Revenue in Q4

Rhea-AI Summary

Nanalysis Scientific Corp. (NSCIF) achieved a new record quarter with unaudited Q4 2023 revenues estimated at $9.3MM to $9.8MM. The company attributes this success to the continued expansion of security services related to its airport security maintenance project and recovery in Benchtop NMR sales. Nanalysis also completed the phase-in period for its airport security maintenance project, resulting in the performance of maintenance of passenger screening imaging and detection equipment across Canada. The company sold and shipped 14 100MHz Benchtop NMR units in Q4, driving continued recovery in Benchtop NMR revenue. Additionally, Nanalysis expanded its patent portfolio with the grant of United States Patent #US 11,815,574B2 for its Benchtop NMR products.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

6.93%

Tags

01/30/2024 08:30 AM

News

Nanalysis Scientific Corp. Provides Update on Security Services Business

Rhea-AI Summary

Nanalysis Scientific Corp. completes the phase-in of Canada-wide coverage at all 89 designated airports, marking a significant milestone in its subsidiary KPrime's security services business. The completion of the CATSA project rollout is expected to generate positive EBITDA in Q1 2024, with revenue projected to increase substantially throughout the year. The company has taken over all preventative and corrective maintenance services for CATSA, positioning itself for future growth opportunities in the security services sector.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

5.67%

Tags

01/03/2024 07:11 PM

News

Nanalysis Scientific Corp. Announces Grant of Restricted Share Units

Rhea-AI Summary

Nanalysis Scientific Corp. (NSCI) announces the grant of 475,000 Restricted Share Units to its independent Directors under the RSU plan, with 100,000 RSUs vesting immediately and the remaining vesting over a three-year period.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

3.71%

Tags

11/29/2023 05:19 PM

News

Nanalysis Reports Third Quarter 2023 Results

Rhea-AI Summary

Nanalysis Scientific Corp. (NSCI) releases its third quarter results ending September 30, 2023, showing an increase in consolidated revenue to $7,036K, a 61% improvement in Benchtop Sales NMR, and a loss before other items of ($1,354K). The company reports continued progress in Security Services and challenges in Benchtop NMR sales.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-9.87%

Tags

11/15/2023 08:30 AM

News

Nanalysis Announces Third Quarter 2023 Conference Call

Rhea-AI Summary

Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) announces a conference call to discuss the results for the quarter ending September 30, 2023, on November 29th, 2023, at 5:00 P.M. Eastern Time. Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will lead the call, which will be available for investors to join via phone or online. Additionally, a Q&A session for European investors will be held on November 30th at 8:30am ET.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

1.24%

Tags